Skip to main content
Medika d.d. logo

Medika d.d. — Investor Relations & Filings

Ticker · MDKA ISIN · HRMDKARA0000 LEI · 74780000O0R8ZVGJJO27 ZSE Wholesale and retail trade
Open in API
Filings indexed 804 across all filing types
Latest filing 2024-10-23 Report Publication Anno…
Country HR Croatia
Listing ZSE MDKA

About Medika d.d.

https://www.medika.hr/en/

Medika d.d. is a pharmaceutical wholesale company specializing in the sale, storage, and distribution of products for the healthcare sector. The company's primary activities encompass the supply of a broad range of goods, including human and veterinary drugs, medical products, dental supplies, and various types of equipment. In addition to its core pharmaceutical distribution, Medika's portfolio also includes dietetic, cosmetic, and hygienic products. The company provides comprehensive logistics and distribution services to a diverse client base within the healthcare market.

Recent filings

Filing Released Lang Actions
Održana sjednica Uprave 23.10.2024..pdf
Report Publication Announcement Classification · 99% confidence The document is very short (840 characters) and explicitly states that the unaudited non-consolidated and consolidated financial statements for the period 01.01.-30.09.2024 have been adopted by the Management Board and will be reviewed by the Supervisory Board on 29.10.2024. This structure—announcing the adoption/completion of financial reports and their subsequent review—is characteristic of a preliminary announcement regarding financial results or the upcoming release of a full report. Since it is an announcement about the adoption of financial statements for a nine-month period (Interim Report), it aligns best with the Earnings Release (ER) category, which covers initial announcements of periodical financial results (key highlights only). It is not the full report itself (IR) nor a general regulatory filing (RNS), as it pertains specifically to earnings data.
2024-10-23 Croatian
Najava sjednice Uprave 23.10.2024..pdf
Board/Management Information Classification · 99% confidence The document is a short announcement dated 18.10.2024 from MEDIKA d.d. titled "PREDMET – NAJAVA SJEDNICE UPRAVE DRUŠTVA" (SUBJECT – ANNOUNCEMENT OF THE MANAGEMENT BOARD MEETING). It states that the Management Board meeting will be held on 23.10.2024 to discuss financial reports for the period 01.01.-30.09.2024. This is an announcement about an upcoming internal event (a board meeting) where financial results will be reviewed, but it is not the financial report itself, nor is it a formal Earnings Release (ER) or Interim Report (IR). It is an announcement regarding internal management/board activity, which aligns best with Board/Management Information (MANG), as it concerns the schedule and agenda of the Management Board meeting.
2024-10-18 Croatian
Održana sjednica Nadzornog odbora 29.08.2024..pdf
AGM Information Classification · 99% confidence The document is a short announcement from MEDIKA d.d. dated August 29, 2024. The subject is 'PREDMET – ODRŽANA SJEDNICA NADZORNOG ODBORA DRUŠTVA' (Subject - Supervisory Board Meeting Held). The key information is that the Supervisory Board approved the non-consolidated and consolidated financial statements for the period 01.01.-30.06.2024. Since this is an announcement regarding the approval of financial statements for a period shorter than a year (H1 2024), it strongly suggests the underlying document is an Interim/Quarterly Report (IR). However, this specific text is merely the announcement of the approval, not the report itself. Given the short length (784 chars) and the nature of announcing the approval of H1 results, it functions as an Earnings Release (ER) or a precursor to the full Interim Report (IR). Since it explicitly mentions the approval of financial statements for the first half of the year, it is most closely aligned with the content of an Earnings Release (ER) which precedes the full IR filing, or it could be classified as a Regulatory Filing (RNS) if it doesn't fit ER perfectly. Given the context of financial results approval, ER is a strong candidate, but since it's an announcement about internal approval rather than the public release of key figures, and it's very short, it could also be seen as a general regulatory announcement. Comparing ER (initial announcement of key highlights) and IR (comprehensive report), this is the announcement of the approval of the H1 statements. If the full report is not attached, this announcement itself is best classified as a general Regulatory Filing (RNS) or potentially an Earnings Release (ER) if the approval implies the imminent release of highlights. Given the focus on the approval of the H1 financial statements, it is a strong indicator of an Earnings Release event, even if the highlights aren't detailed here. However, based on the 'MENU VS MEAL' rule, if this is just the announcement of approval, RNS is safer, but ER is more specific to the financial period mentioned. I will lean towards ER as the subject matter is the core of an earnings announcement.
2024-08-29 Croatian
Najava sjednice Nadzornog odbora 29.08.2024..pdf
Board/Management Information Classification · 99% confidence The document is a short announcement dated August 26, 2024, from MEDIKA d.d. The subject is 'PREDMET – NAJAVA SJEDNICE NADZORNOG ODBORA' (SUBJECT – NOTICE OF SUPERVISORY BOARD MEETING). The text explicitly states that the Supervisory Board meeting will be held on 29.08.2024 to discuss financial reports for the period 01.01.-30.06.2024. Since this is a short notice announcing a future meeting where reports will be reviewed, and it is not the report itself, it fits the description of an announcement regarding the publication or review of reports. Given the options, this is a general regulatory announcement concerning internal governance/reporting schedule, but the most fitting category for an announcement about upcoming review of financial results (which are usually released shortly after) or a governance meeting notice, when a specific 'Meeting Notice' code is absent, is often RPA (Report Publication Announcement) if it implies the results are forthcoming, or RNS (Regulatory Filings) as a general catch-all. However, since it is a formal notice about a board meeting agenda that includes reviewing financial reports, it is primarily a governance/procedural announcement. Given the short length and the nature of announcing a future event where reports will be discussed, it is best classified as a Report Publication Announcement (RPA) if the intent is to signal the upcoming release of those financial results, or RNS if it's purely procedural. Since the document is a formal notice about a board meeting agenda that includes reviewing financial reports, and it is not the financial report itself, RPA is a strong candidate as it announces the context for future report publication, or RNS as a general regulatory notice. Given the context of financial reporting review, RPA is slightly more specific than RNS, but since it's a notice of a *meeting* rather than a notice of *report publication*, RNS (Regulatory Filings) serves as the safest general regulatory announcement fallback for procedural notices not covered elsewhere.
2024-08-26 Croatian
tfi-pod-eur-Grupa Medika-hrv.xlsx
Financial Supplement Data
2024-07-26 Croatian
Konsolidirani financijski izvještaji Grupa Medika d.d. 30.06.2024..pdf
Interim / Quarterly Report Classification · 100% confidence The document is a 'Međuinvještaj poslovodstva' (Management Interim Report) for the first half of 2024 (I-VI 2024). It contains detailed financial analysis, balance sheet data, income statement highlights, and management commentary on business trends, risks, and outlook. It is a comprehensive report covering a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2024
2024-07-26 Croatian

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.